A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of the Kappa Opioid Receptor Antagonist JNJ-67953964 (Aticaprant) as Adjunctive Treatment for Major Depressive Disorder
NEUROPSYCHOPHARMACOLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要